Reporter

Cancer cells combine tools to increase invasiveness

Two features of invasive cancer cells — invadopodia and exosomes — are linked together, Vanderbilt University investigators have discovered.

Biodegradable scaffold may spur wound healing

Biomedical and chemical engineers at Vanderbilt University, working with a pathologist, have constructed a sponge-like, biodegradable tissue “scaffold” that releases an enzyme-blocking molecule to indirectly activate endogenous pathways and enhance tissue regeneration and wound healing.

VU study identifies new gene fusions in melanoma

Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer.

VUMC positioned to meet challenges ahead: Balser

“The downsizing effort is over.” With those words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

Cancer drug enhances cognition

The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.